Leadership Overview
INCYTE has 4 executives leading key functions including strategy, financial operations, information technology, and medical research.
Committed to advancing life-changing science, INCYTE delivers innovative biopharmaceutical solutions to patients battling complex cancers. This organization prioritizes rigorous clinical development and commercial excellence to transform therapeutic standards across the global healthcare landscape.
Committed to advancing life-changing science, INCYTE delivers innovative biopharmaceutical solutions to patients battling complex cancers. This organization prioritizes rigorous clinical development and commercial excellence to transform therapeutic standards across the global healthcare landscape.
Leadership Roles at INCYTE
Bill Meury - Chief Executive Officer
Bill Meury, the Chief Executive Officer at INCYTE, directs the overarching corporate strategy and long-term vision for the biopharmaceutical enterprise. Overseeing the commercialization of critical therapeutics like JAKAFI and Iclusig, the Chief Executive Officer ensures alignment between research milestones and market delivery. This leadership role involves constant engagement with the Board to optimize resource allocation for oncology drug development. By fostering a culture of scientific rigor, Meury drives the expansion of the company portfolio within the United States and beyond. The Chief Executive Officer maintains focus on sustainable growth while addressing the urgent needs of patients with myelofibrosis and leukemia. Through disciplined execution of business objectives, Bill Meury secures the competitive position of the firm in the highly regulated pharmaceutical sector, ultimately delivering value to stakeholders and patients alike.

Suky Upadhyay - Executive Vice President & Chief Financial Officer
Suky Upadhyay, the Executive Vice President & Chief Financial Officer at INCYTE, manages the financial health and capital allocation strategies of the organization. Overseeing fiscal planning, the Executive Vice President & Chief Financial Officer ensures the availability of funding for complex drug discovery and clinical trial programs. This role involves rigorous analysis of market trends to support the commercial success of kinase inhibitors and other oncology assets. By maintaining robust financial controls, Upadhyay supports the operational scale required for North American market dominance. The Executive Vice President & Chief Financial Officer collaborates with executive leadership to balance investment in innovation with profitability targets. Suky Upadhyay provides the necessary financial oversight to navigate the volatile biopharmaceutical landscape, ensuring that the company maintains the liquidity required to sustain long-term research initiatives and patient-focused therapeutic development.

Andrew Blyton - Vice President & Chief Information Officer
Andrew Blyton, the Vice President & Chief Information Officer at INCYTE, architects the digital infrastructure and data management systems essential for modern biopharmaceutical operations. Overseeing the integration of advanced analytics, the Vice President & Chief Information Officer ensures that research teams possess the computational power to accelerate drug discovery processes. This role involves securing proprietary data assets while enabling seamless collaboration across global research sites. By implementing scalable technology solutions, Blyton supports the efficient commercialization of therapeutics like JAKAFI. The Vice President & Chief Information Officer aligns technical capabilities with the broader corporate mission to improve patient outcomes through data-driven insights. Andrew Blyton maintains the integrity of information systems, providing the backbone for clinical trial management and regulatory compliance. Through continuous digital transformation, the Vice President & Chief Information Officer enhances operational agility and supports the overall strategic goals of the firm.
Steven Stein - Chief Medical Officer
Steven Stein, the Chief Medical Officer at INCYTE, leads the clinical development and medical strategy for the entire therapeutic pipeline. Overseeing the transition of compounds from laboratory discovery to clinical application, the Chief Medical Officer ensures that all drug candidates meet the highest standards of safety and efficacy. This role involves managing complex interactions with regulatory bodies to facilitate the approval of treatments for myelofibrosis and chronic myeloid leukemia. By directing clinical trial design, Stein ensures that research efforts directly address unmet patient needs. The Chief Medical Officer collaborates with the commercial team to communicate the clinical value of the company portfolio to healthcare providers. Steven Stein maintains a focus on scientific excellence, driving the advancement of kinase inhibitors through rigorous testing phases. Through this medical leadership, the Chief Medical Officer shapes the future of oncology care and strengthens the market impact of the organization.
Explore Leadership Teams in Manufacturing
AbbVie Inc. is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines and health solutions that address some of the worlds most complex medical challenges. Headquartered in North Chicago, Illinois, the company operates internationally and focuses on advancing treatments that improve patient outcomes and overall quality of life. AbbVies scientific and commercial efforts are concentrated in several core therapeutic areas, including immunology, oncology, neuroscience, eye care, and medical aesthetics, along with other specialty areas where significant unmet medical needs exist. Through these focus areas, the company works to create therapies that help patients manage chronic, serious, and often life-altering diseases.
Company Leadership BG
MS
Founded and headquartered in Darmstadt, Germany, Merck KGaA is a multinational pharmaceutical, chemical and life sciences company. Merck operates in Europe, Africa, Asia, Oceania and the Americas. It has major research and development centres in Darmstadt, Boston, Tokyo and Beijing.
Company Leadership CO
Akums, headquartered in Delhi, India, is an international WHO-GMP certified integrated pharmaceutical manufacturing company.
Company Leadership AN
IG
AS
At Simtra, the company is dedicated to developing and manufacturing quality sterile injectable products to meet evolving patient needs. The company works with precision and transparency, setting high standards and paying attention to every detail, in order to ensure that the company makes your product right the first time, deliver it on time and meet your requirements in full. The company is made for this, with the company's extensive slate of services and product delivery options.
Company Leadership


